Live·Open questions in longevity research
← Questions

In people with age-related immune dysfunction, what conditions are necessary and jointly sufficient to durably restore key functions of innate and adaptive immunity to levels within the ranges observed in healthy young adults, while preserving protective immunological memory, self-tolerance, and control of latent infections?

Do protection failures reflect missing recognition or blocked tissue access, and can restoring access rescue existing immune cells?

Recognizing a threat and providing protection where it occurs are separate steps in the mechanism proposed by the question. If suitable cells are absent, allowing existing cells into a tissue would not by itself supply the missing recognition.

The whole reason

If suitable cells already exist but cannot reach the relevant location, improved access could potentially let them provide protection. Mistaking either situation for the other could lead to treating a better blood-test result as restored protection while the limiting step remains unresolved. These are conditional consequences of the question's proposed mechanism, not outcomes established by the supplied sources.

The question in full

The question concerns why people with age-related immune dysfunction might remain poorly protected even when blood tests suggest improvement. It asks whether the immune system lacks cells that recognize a particular threat, or whether suitable cells exist but cannot reach the tissue locations where protection is needed. The proposed intervention is to restore that local access, comparing protection before and after while establishing whether new immune-cell clones were generated. The question assumes that improved blood repertoires and fixed functional panels can coexist with failures of protection, and that missing recognition and failed local deployment can be distinguished as causes.

Competing hypotheses

These hypotheses propose different mechanisms. Comparing their predictions helps identify observations that could distinguish them.

  1. 01Dominant recalled immune cells can sustain infection by killing local support cellsIn a subset of older adults, recalled cytotoxic T cells may sustain tissue infection by killing uninfected dendritic cells. In autologous infected tissue cultures, removing the dominant population must improve presenter survival before pathogen control; adding it back must reverse rescue.
  2. 02Delayed nutrient depletion causes recurring gaps in local immune protectionIn perfused autologous tissue cultures, the hypothesis predicts that delayed tryptophan depletion disables protective cells already present. Restoring tryptophan during the depleted phase must rescue protection better than an equal-total supplement outside that phase.
  3. 03The blood vessel lining kills protective immune cells as they enter tissueIn endothelial cultures under flow coupled to a person's own tissue, existing protective lymphocytes could restore local protection if entry-associated death is the defect. Blocking endothelial Fas ligand or placing the same cells beyond the lining would rescue entry or protection without changing their receptors.
Each entry represents a published hypothesis. Where no hypotheses are published yet, the entries show possible answers to the scientific question.

What results would tell us about the hypotheses

Choose a possible result to see which hypothesis it would support, what the alternatives predict, and what would need to be tested next.

If we observe
In autologous infected tissue cultures, selectively removing the dominant event-associated cytotoxic population reduces viable pathogen burden across repeated challenges despite reducing cognate cytotoxic-cell abundance. Live imaging must show that presenter survival improves before pathogen control improves. Adding the same population back restores presenter loss and impaired control. Removing presenters from the rescued culture abolishes rescue. Access enhancement or addition of more cells with the dominant specificity instead worsens control. These outcomes distinguish destructive recall from insufficient access, nutrient suppression, and a missing-specificity explanation. Hypothetical result
Would support the hypothesis
Dominant recalled immune cells can sustain infection by killing local support cells — In a subset of older adults, recalled cytotoxic T cells may sustain tissue infection by killing uninfected dendritic cells. In autologous infected tissue cultures, removing the dominant population must improve presenter survival before pathogen control; adding it back must reverse rescue.
Other hypotheses predict
  • Delayed nutrient depletion causes recurring gaps in local immune protection — During repeated challenge, local effector activity rises before IDO1 activity rises and tryptophan falls; loss of protection follows that trough. A phase-targeted tryptophan clamp restores protection more effectively than an equal-total supplement delivered outside the trough, with receptor membership and cellular access held constant. Rescue must persist when kynurenine exposure is experimentally matched. Directly placing additional competent cells in the tissue fails during the trough, whereas existing cells recover after nutrient restoration. Failure to detect the predicted ordering or phase dependence rejects the delay mechanism.
  • The blood vessel lining kills protective immune cells as they enter tissue — In a perfused endothelial–tissue preparation, event-reactive cells undergo caspase activation at the endothelial interface before accumulating in tissue. Endothelial-restricted FasL interruption restores viable entry and pathogen control. Direct placement of the same cells beyond the interface produces equivalent rescue without changing their receptors. Adding more relevant cells upstream fails, while unrelated-specificity controls do not rescue. Nutrient restoration alone does not prevent entry-associated death.
What to check next
When protection fails despite improved blood immune measurements, is relevant threat recognition absent, is tissue access limited, or are both involved?

These are hypothetical results. Selecting one shows what would follow from it; it does not confirm a hypothesis or change its assessment.

Comparing hypotheses

Compare the proposed mechanisms, the predictions that distinguish the hypotheses, and the observations that would count against each one.

01

Dominant recalled immune cells can sustain infection by killing local support cells

Effector induced support cell deletion
Proposed mechanism

In a subset of older adults, recalled cytotoxic T cells may sustain tissue infection by killing uninfected dendritic cells.

Full text

In a subset of older adults with discordant tissue infections, abundant recalled cytotoxic T cells destroy uninfected, antigen-bearing local dendritic cells faster than they eliminate infected targets. This removes the cellular support required by other protective responses. The maladaptive state is sustained by repeated destruction of replacement presenters, rather than absent protective receptors. Increasing local access of the dominant recalled specificity worsens protection; temporarily excluding that specificity permits existing alternative effectors to restore control. Preventing this destructive interaction stabilizes SPV_7 while preserving established protection elsewhere.

What distinguishes its prediction

In autologous infected tissue cultures, selectively removing the dominant event-associated cytotoxic population reduces viable pathogen burden across repeated challenges despite reducing cognate cytotoxic-cell abundance.

Full text

Live imaging must show that presenter survival improves before pathogen control improves. Adding the same population back restores presenter loss and impaired control. Removing presenters from the rescued culture abolishes rescue. Access enhancement or addition of more cells with the dominant specificity instead worsens control. These outcomes distinguish destructive recall from insufficient access, nutrient suppression, and a missing-specificity explanation.

What would weaken the hypothesis

Delayed nutrient depletion causes recurring gaps in local immune protection predicts instead: During repeated challenge, local effector activity rises before IDO1 activity rises and tryptophan falls; loss of protection follows that trough.

Full text

A phase-targeted tryptophan clamp restores protection more effectively than an equal-total supplement delivered outside the trough, with receptor membership and cellular access held constant. Rescue must persist when kynurenine exposure is experimentally matched. Directly placing additional competent cells in the tissue fails during the trough, whereas existing cells recover after nutrient restoration. Failure to detect the predicted ordering or phase dependence rejects the delay mechanism.

The blood vessel lining kills protective immune cells as they enter tissue predicts instead: In a perfused endothelial–tissue preparation, event-reactive cells undergo caspase activation at the endothelial interface before accumulating in tissue. Endothelial-restricted FasL interruption restores viable entry and pathogen control. Direct placement of the same cells beyond the interface produces equivalent rescue without changing their receptors. Adding more relevant cells upstream fails, while unrelated-specificity controls do not rescue. Nutrient restoration alone does not prevent entry-associated death.

02

Delayed nutrient depletion causes recurring gaps in local immune protection

Resource and energy
Proposed mechanism

In perfused autologous tissue cultures, the hypothesis predicts that delayed tryptophan depletion disables protective cells already present.

Full text

Protective specificities reach the implicated tissue, but their activation induces delayed stromal or myeloid tryptophan catabolism through IDO1. The resulting nutrient trough arrives after initial expansion and disables maintenance or renewed deployment of those same cells. Slow recovery and repeated exposure produce recurrent local protection gaps despite competent blood responses. The proposed causal defect is excessive delay and gain in extracellular nutrient turnover, not a receptor-recognition defect or a permanently altered lymphocyte state. Correcting the timing of nutrient recovery stabilizes SPV_7 without introducing new clones.

What distinguishes its prediction

During repeated challenge, local effector activity rises before IDO1 activity rises and tryptophan falls; loss of protection follows that trough.

Full text

A phase-targeted tryptophan clamp restores protection more effectively than an equal-total supplement delivered outside the trough, with receptor membership and cellular access held constant. Rescue must persist when kynurenine exposure is experimentally matched. Directly placing additional competent cells in the tissue fails during the trough, whereas existing cells recover after nutrient restoration. Failure to detect the predicted ordering or phase dependence rejects the delay mechanism.

What would weaken the hypothesis

Dominant recalled immune cells can sustain infection by killing local support cells predicts instead: In autologous infected tissue cultures, selectively removing the dominant event-associated cytotoxic population reduces viable pathogen burden across repeated challenges despite reducing cognate cytotoxic-cell abundance.

Full text

Live imaging must show that presenter survival improves before pathogen control improves. Adding the same population back restores presenter loss and impaired control. Removing presenters from the rescued culture abolishes rescue. Access enhancement or addition of more cells with the dominant specificity instead worsens control. These outcomes distinguish destructive recall from insufficient access, nutrient suppression, and a missing-specificity explanation.

The blood vessel lining kills protective immune cells as they enter tissue predicts instead: In a perfused endothelial–tissue preparation, event-reactive cells undergo caspase activation at the endothelial interface before accumulating in tissue. Endothelial-restricted FasL interruption restores viable entry and pathogen control. Direct placement of the same cells beyond the interface produces equivalent rescue without changing their receptors. Adding more relevant cells upstream fails, while unrelated-specificity controls do not rescue. Nutrient restoration alone does not prevent entry-associated death.

03

The blood vessel lining kills protective immune cells as they enter tissue

Interfaces and barriers
Proposed mechanism

In endothelial cultures under flow coupled to a person's own tissue, existing protective lymphocytes could restore local protection if entry-associated death is the defect.

Full text

The implicated tissue contains an endothelial death barrier: arriving protective effector cells encounter endothelial Fas ligand and undergo apoptosis during entry. Blood therefore retains useful specificities while repeated local replacement attempts fail. The defect is execution of incoming cells at the vascular interface, rather than physical tissue geometry, missing antigen recognition, or stochastic extinction of receptor lineages. Preventing entry-associated apoptosis allows existing circulating specificities to restore local function and stabilizes SPV_7.

What distinguishes its prediction

In a perfused endothelial–tissue preparation, event-reactive cells undergo caspase activation at the endothelial interface before accumulating in tissue.

Full text

Endothelial-restricted FasL interruption restores viable entry and pathogen control. Direct placement of the same cells beyond the interface produces equivalent rescue without changing their receptors. Adding more relevant cells upstream fails, while unrelated-specificity controls do not rescue. Nutrient restoration alone does not prevent entry-associated death.

What would weaken the hypothesis

Dominant recalled immune cells can sustain infection by killing local support cells predicts instead: In autologous infected tissue cultures, selectively removing the dominant event-associated cytotoxic population reduces viable pathogen burden across repeated challenges despite reducing cognate cytotoxic-cell abundance.

Full text

Live imaging must show that presenter survival improves before pathogen control improves. Adding the same population back restores presenter loss and impaired control. Removing presenters from the rescued culture abolishes rescue. Access enhancement or addition of more cells with the dominant specificity instead worsens control. These outcomes distinguish destructive recall from insufficient access, nutrient suppression, and a missing-specificity explanation.

Delayed nutrient depletion causes recurring gaps in local immune protection predicts instead: During repeated challenge, local effector activity rises before IDO1 activity rises and tryptophan falls; loss of protection follows that trough. A phase-targeted tryptophan clamp restores protection more effectively than an equal-total supplement delivered outside the trough, with receptor membership and cellular access held constant. Rescue must persist when kynurenine exposure is experimentally matched. Directly placing additional competent cells in the tissue fails during the trough, whereas existing cells recover after nutrient restoration. Failure to detect the predicted ordering or phase dependence rejects the delay mechanism.

No test is published for this question yet

The hypotheses above state the observations that could distinguish them. A proposed experiment for this question has not yet been published.

What to check next: When protection fails despite improved blood immune measurements, is relevant threat recognition absent, is tissue access limited, or are both involved?

Every proposed test →

What the literature settles, and what it does not

The sources read against this question, the assumption it rests on, and the verdict that follows.

Do protection failures reflect missing recognition or blocked tissue access, and can restoring access rescue existing immune cells?

What this question is asking

The question concerns why people with age-related immune dysfunction might remain poorly protected even when blood tests suggest improvement. It asks whether the immune system lacks cells that recognize a particular threat, or whether suitable cells exist but cannot reach the tissue locations where protection is needed. The proposed intervention is to restore that local access, comparing protection before and after while establishing whether new immune-cell clones were generated. The question assumes that improved blood repertoires and fixed functional panels can coexist with failures of protection, and that missing recognition and failed local deployment can be distinguished as causes.

What the terms mean
Age-related immune dysfunction
Changes associated with aging that reduce how well the body's defenses work. The question concerns people with these changes, but the supplied material does not define a single diagnostic threshold.
Protection gap or clinical protection failure
A situation in which immune defenses do not provide the protection being assessed. The input does not specify a particular infection, tissue, severity measure, or time period.
Immune specificity or threat recognition
The particular target an immune recognition system can detect. Missing specificity means that recognition of a relevant target is absent, rather than simply that the overall number of immune cells is low.
Blood repertoire
The collection of immune recognition types detected in a blood sample. Its membership or diversity is a measurement of sampled recognition types, not a direct measurement of protection throughout the body.
Functional panel
A selected set of tests measuring immune activities. A fixed panel covers its chosen activities; the input does not establish which activities were tested or what improvement means.
Tissue niche, local access, and deployment
A tissue niche is a local setting within an organ or body tissue where immune cells may need to operate. Access concerns reaching that setting, while deployment concerns being present where the needed response occurs; neither term alone establishes that cells survive or function there.
Immune-cell clone and lineage
A clone is a family of immune cells descended from a common starting cell; a lineage describes their related ancestry. Rescue without new clones means that improvement must be accounted for by existing families rather than newly generated ones.
Antibody and antibody-secreting cell
An antibody is an immune protein that recognizes a target, and an antibody-secreting cell releases these proteins. S7 measures such cells in blood after vaccination, which does not by itself establish where they subsequently act.
Naive repertoire and intralineage diversification
The naive repertoire comprises recognition types available among cells that have not yet entered a response to their matching target. Intralineage diversification means variation developing within related cell families; S1 describes reduced availability of the former and reduced fine-tuning through the latter in older participants.
T cell and T-cell receptor repertoire
A T cell is a type of immune cell whose receptor participates in recognizing targets. The receptor repertoire is the collection of recognition types across these cells, which S2 describes as contracting with age.
Tissue-resident memory T cell
A T cell associated with lasting immune memory that remains in a tissue. Its local presence, survival, target recognition, and protective activity are distinct properties in this question.
Plasma and brain white matter
Plasma is the liquid portion of blood. White matter is brain tissue containing nerve-fiber connections; S6 reports immune-cell accumulation there after mice received plasma.
Mucosal tissue and immunoglobulin A
Mucosal tissues line surfaces such as the respiratory and digestive passages. Immunoglobulin A is a class of antibody; S9 reports its induction in the nose after vaccination through the nose.
Vaccination route
The way a vaccine enters the body, such as through the mouth, through the nose, or into muscle. S9 compares routes, which does not isolate restoration of access for already existing cells.
Preclinical study
Research conducted before establishing an effect in humans. The supplied description identifies S9 as preclinical and explicitly says it does not establish the requested result in humans.
What the question takes for granted
Premise not found in what was read
Apparently successful renewal, reflected in improved blood repertoires and functional panels, can conflict with clinical protection, and the resulting protection gaps can be distinguished as absent specificities versus failed local deployment.

Blood repertoires describe the collection of immune recognition types found in blood, while functional panels test a selected set of immune activities. The assumption is that these measurements can improve while protection still fails because either the necessary recognition is missing or suitable cells cannot reach the tissue that needs them. If established, this would explain why favorable blood measurements might leave a specific protective requirement unmet.

The supplied searches did not return evidence establishing this particular mismatch after apparent renewal or the proposed distinction between its causes. S1 reports age-related changes in blood antibody repertoires, S6 reports immune-cell accumulation alongside a marker involved in cell movement, and S9 reports different local immune responses after different vaccination routes. None establishes the asserted sequence of improved blood measurements followed by a protection failure attributable to one of the two proposed causes. This bounded set does not show that the premise is false.S1S6S9

The same question asked without the part nothing read establishes:

  • When protection fails despite improved blood immune measurements, is relevant threat recognition absent, is tissue access limited, or are both involved?
  • Can restoring tissue access improve protection using existing immune-cell clones without generating new ones?
What turns on the answer
  • The necessary recognition is missing Under this explanation, the existing cells cannot recognize the threat responsible for the protection failure. Restoring access alone would therefore leave that missing recognition unresolved, even if more cells reached the tissue.
  • Existing cells are blocked from the tissue Under this explanation, cells with the necessary recognition already exist but cannot reach the relevant location. If access is the limiting step, restoring it could improve protection without generating new clones; the supplied sources do not demonstrate this rescue.
  • Both limitations contribute, or neither is sufficient Restoring access could leave missing recognition unresolved, while having suitable recognition could leave local deployment unresolved. A protection failure would then resist explanation by the proposed either-or distinction, and improved blood measurements alone would not identify the remaining limitation.
Why it matters

Recognizing a threat and providing protection where it occurs are separate steps in the mechanism proposed by the question. If suitable cells are absent, allowing existing cells into a tissue would not by itself supply the missing recognition. If suitable cells already exist but cannot reach the relevant location, improved access could potentially let them provide protection. Mistaking either situation for the other could lead to treating a better blood-test result as restored protection while the limiting step remains unresolved. These are conditional consequences of the question's proposed mechanism, not outcomes established by the supplied sources.

Still open

None of the read sources settles the causal fork or demonstrates rescue without new clones. The nearest findings concern age-related repertoire contraction in S1 and S2, survival of local memory cells in S5, cell accumulation associated with a movement-related molecule in S6, and vaccination-route differences in local responses in S9. The inference from these findings is that they address separate components of the question without connecting them in the required causal test. 'Open' describes what remains unresolved in this supplied set, not proof that no answer exists elsewhere in the literature.S1S2S5S6S9

What the literature establishes
  • S1 reports that older participants had a smaller naive antibody repertoire and less diversification within related immune-cell lineages than younger participants. The source interprets these findings as less capacity for new responses and less fine-tuning of recognition; it does not report protection after successful renewal.S1
  • S2 states that contraction of the T-cell receptor repertoire likely explains declining immunity with age. Its wording presents an explanation, rather than a direct comparison of missing recognition with failed tissue access.S2
  • In the mouse study S5, a reduction in tissue-resident memory T-cell populations was attributed partly to increased sensitivity to cell-death triggers when the studied protein was absent. This finding concerns survival of local cells, rather than a demonstrated barrier preventing existing cells from entering tissue.S5
  • S6 reports that a group of T cells accumulated in brain white matter in mice given plasma, coinciding with expression on brain blood vessels of a molecule involved in immune-cell movement. The quoted finding is an association and does not establish restored protection.S6
  • S7 reports that antibody-secreting cells appear in human blood after oral vaccination. It describes their movement toward mucosal tissue as a belief based on animal experiments, rather than as directly established by the quoted human observation.S7
  • S9 reports that vaccination through the nose, but not vaccination into muscle, induced nasal immunoglobulin A and tissue-resident memory T cells in the lung. This preclinical result distinguishes local immune responses by delivery route, but does not show rescue through access alone or exclude generation of new clones.S9
What it does not settle
  • Whether improved blood repertoires and functional panels coexist with the specific protection failures described in the question, and how those failures are measured.S1S2S9
  • Whether any such failure is caused by absent threat recognition, inaccessible tissue locations, loss of local cells, or a combination. The supplied sources do not establish that the question's two explanations exhaust the possibilities.S1S5S6S9
  • Whether restoring local access rescues protection without generating new immune-cell clones. None of the supplied source summaries reports a test establishing that result.
  • Whether any rescue applies to people with age-related immune dysfunction, how large or durable it is, or whether it preserves previous immune protection, avoids attacks on the body's own tissues, and maintains control of persistent infections.
  • The supplied material gives no validated separate limits for local protection, no measurement thresholds, and no established timing rule for expanded assessment after a protection failure.
  • The available excerpts also limit interpretation: S3 supplies an incomplete background sentence, S4 supplies no verified result quote, and S8 describes possible infection susceptibility rather than a demonstrated effect. These cannot close the causal gap.S3S4S8
Sources read · 10

4 literature searches, 7 full texts, 3 abstract-only; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Partly answers it

Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging. · Proceedings of the National Academy of Sciences of the United States of America · 2017

“Relative to their younger counterparts, older subjects demonstrated a contracted naive repertoire and diminished intralineage diversification, signifying a reduced substrate for mounting novel responses and decreased fine-tuning of BCR specificities by somatic hypermutation.”

Does not settle: This peripheral-blood antibody-repertoire study does not establish whether protection gaps arise from absent specificities versus inaccessible tissue niches, and it does not test restoring local access or rescuing function without generating new clones.

S2Partly answers itAbstract only

Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. · Experimental gerontology · 2005

“T-cell receptor (TCR) repertoire contraction likely explains the decline in immunity with chronological age as evidenced by the increased morbidity and mortality to common and new infections, and the low rates of protective responses to vaccination in the elderly.”

Does not settle: It does not examine tissue niches, local access or restoration of local access, nor test whether function can be rescued without generating new clones.

S3Background

Tissue-specific immunity for a changing world. · Cell · 2021

“While blood is the most readily sampled site for investigations of human immune cells, studies from the past decade using tissue samples obtained from surgical explants and more recently, from human organ donors”

Does not settle: It does not establish whether protection gaps after improved blood repertoires and functional panels result from absent specificities versus inaccessible tissue niches, nor whether restoring local access rescues function without generating new clones.

S4Background

Keeping T cell memories in mind. · Trends in immunology · 2022

Does not settle: The supplied text is a reference-list fragment and does not report results on blood repertoires, protection gaps, tissue access, functional rescue, or generation of new clones.

S5Partly answers it

STING promotes homeostatic maintenance of tissues and confers longevity with aging. · bioRxiv : the preprint server for biology · 2024

“Here, we reveal that in the case of STING-deficiency, the contraction of TRM populations is in part due to increased sensitivity of STING −/− TRMs to key cell-death triggers.”

Does not settle: This mouse study does not assess blood repertoires or functional panels, determine whether protection gaps reflect absent specificities versus inaccessible tissue niches, or test whether restoring local access rescues function without generating new clones.

S6BackgroundAbstract only

Age-associated systemic factors change central and peripheral immunity in adult male mice. · Brain, behavior, and immunity · 2023

“Notably, CD8+ T cells accumulated within white matter areas of plasma-treated mice, which coincided with the expression of vascular cell adhesion molecule 1 (VCAM-1), a mediator of immune cell trafficking, on the brain vasculature.”

Does not settle: This abstract does not test protection gaps, absent immune specificities, restoration of local tissue access, functional rescue, or whether new clones are generated.

S7BackgroundAbstract only

Peripheral blood antibody-secreting cells in the evaluation of the immune response to an oral vaccine. · Journal of biotechnology · 1996

“Specific antibody-secreting cells (ASC) appear in the blood as a response to oral vaccination in humans. Based on information from animal experiments, these cells are believed to be migrating to the mucosa.”

Does not settle: The abstract does not test whether protection gaps arise from absent specificities versus inaccessible tissue niches, or whether restoring local access rescues function without generating new clones.

S8Background

Dietary restriction impacts health and lifespan of genetically diverse mice. · Nature · 2024

“changes in immune repertoire that could potentially confer susceptibility to infection.”

Does not settle: It does not establish whether protection gaps reflect absent specificities or inaccessible tissue niches, nor whether restoring local access rescues function without generating new clones.

S9Partly answers it

An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission. · bioRxiv : the preprint server for biology · 2022

“Indeed, the i.n., but not i.m., immunizations with S-Fc induce nasal IgA and TRM T cells in the lung.”

Does not settle: This preclinical study does not establish whether protection gaps after improved blood repertoires are caused by absent specificities versus inaccessible tissue niches. It does not test restoration of local access without generating new clones, track clonotypes, or establish this in humans.

S10Background

The cell-surface 5'-nucleotidase CD73 defines a functional T memory cell subset that declines with age. · Cell reports · 2021

“This population is declining with age, but we do not know the mechanisms that causes this decline.”

Does not settle: It does not compare absent antigen specificities with inaccessible tissue niches, assess improved blood repertoires or functional panels, or test whether restoring local tissue access rescues function without generating new clones.

← Every open question